Zoetis Revenue 2011-2019 | ZTS

Zoetis annual/quarterly revenue history and growth rate from 2011 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Zoetis revenue for the quarter ending September 30, 2019 was $1.584B, a 7.03% increase year-over-year.
  • Zoetis revenue for the twelve months ending September 30, 2019 was $6.150B, a 7.5% increase year-over-year.
  • Zoetis annual revenue for 2018 was $5.825B, a 9.76% increase from 2017.
  • Zoetis annual revenue for 2017 was $5.307B, a 8.57% increase from 2016.
  • Zoetis annual revenue for 2016 was $4.888B, a 2.58% increase from 2015.
Zoetis Annual Revenue
(Millions of US $)
2018 $5,825
2017 $5,307
2016 $4,888
2015 $4,765
2014 $4,785
2013 $4,561
2012 $4,336
2011 $4,233
2010 $3,582
Zoetis Quarterly Revenue
(Millions of US $)
Q3 2019 $1,584
Q2 2019 $1,547
Q1 2019 $1,455
Q4 2018 $1,564
Q3 2018 $1,480
Q2 2018 $1,415
Q1 2018 $1,366
Q4 2017 $1,460
Q3 2017 $1,347
Q2 2017 $1,269
Q1 2017 $1,231
Q4 2016 $1,277
Q3 2016 $1,241
Q2 2016 $1,208
Q1 2016 $1,162
Q4 2015 $1,274
Q3 2015 $1,214
Q2 2015 $1,175
Q1 2015 $1,102
Q4 2014 $1,320
Q3 2014 $1,210
Q2 2014 $1,158
Q1 2014 $1,097
Q4 2013 $1,254
Q3 2013 $1,103
Q2 2013 $1,114
Q1 2013 $1,090
Q4 2012 $1,176
Q3 2012 $1,019
Q2 2012 $1,094
Q1 2012 $1,047
Q4 2011
Q4 2010
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $59.218B $5.825B
Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $63.340B 10.01
Astellas Pharma (ALPMY) Japan $32.299B 16.13
Eisai (ESALY) Japan $21.220B 40.92
Grifols, S.A (GRFS) Spain $15.628B 20.48
UCB SA (UCBJF) Belgium $15.483B 0.00
Merck (MKGAF) Germany $14.519B 19.81
Neurocrine Biosciences (NBIX) United States $10.262B 484.48
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
Ionis Pharmaceuticals (IONS) United States $8.752B 17.73
Jazz Pharmaceuticals (JAZZ) Ireland $8.480B 10.83
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.449B 0.00
Catalent (CTLT) United States $7.643B 31.09
IPSEN SA ADR (IPSEY) France $7.310B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $6.443B 97.57
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.226B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Hypermarcas (HYPMY) Brazil $5.026B 18.07
FibroGen (FGEN) United States $4.157B 122.15
United Therapeutics (UTHR) United States $4.114B 0.00
Nektar Therapeutics (NKTR) United States $3.833B 0.00
Sage Therapeutics (SAGE) United States $3.761B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.591B 13.13
Evotec AG (EVTCY) Germany $3.498B 57.24
PTC Therapeutics (PTCT) United States $2.941B 0.00
ArQule (ARQL) United States $2.413B 0.00
Heron Therapeutics (HRTX) United States $2.302B 0.00
Zogenix (ZGNX) United States $2.136B 0.00
Xencor (XNCR) United States $2.127B 64.65
Portola Pharmaceuticals (PTLA) United States $2.093B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.979B 63.10
ChemoCentryx (CCXI) United States $1.932B 0.00
Tilray (TLRY) Canada $1.903B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.899B 56.19
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.721B 0.00
USANA Health Sciences (USNA) United States $1.654B 17.64
Corcept Therapeutics (CORT) United States $1.527B 18.56
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.507B 10.29
Enanta Pharmaceuticals (ENTA) United States $1.295B 29.58
CLINIGEN GP (CLIGF) United Kingdom $1.245B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.196B 0.00
Karyopharm Therapeutics (KPTI) United States $1.068B 0.00
Endo (ENDP) Ireland $1.066B 1.96
Radius Health (RDUS) United States $1.034B 0.00
Aerie Pharmaceuticals (AERI) United States $1.024B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.983B 0.00
Flexion Therapeutics (FLXN) United States $0.795B 0.00
Akebia Therapeutics (AKBA) United States $0.755B 0.00
Dermira (DERM) United States $0.702B 0.00
Collegium Pharmaceutical (COLL) United States $0.694B 0.00
TherapeuticsMD (TXMD) United States $0.643B 0.00
ImmunoGen (IMGN) United States $0.542B 0.00
Translate Bio (TBIO) United States $0.535B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.529B 0.00
Ardelyx (ARDX) United States $0.470B 0.00
Organogenesis Holdings (ORGO) United States $0.445B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.445B 54.00
BioSpecifics Technologies Corp (BSTC) United States $0.440B 18.98
BioCryst Pharmaceuticals (BCRX) United States $0.439B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.436B 0.00
Harpoon Therapeutics (HARP) United States $0.435B 0.00
Molecular Templates (MTEM) United States $0.413B 0.00
Indivior (INVVY) United States $0.412B 1.49
OptiNose (OPTN) United States $0.393B 0.00
Recro Pharma (REPH) United States $0.381B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.379B 0.00
Innate Pharma SA (IPHYF) France $0.375B 0.00
DURECT (DRRX) United States $0.371B 0.00
Lannett Co Inc (LCI) United States $0.369B 4.30
Siga Technologies (SIGA) United States $0.369B 8.43
Corbus Pharmaceuticals Holdings (CRBP) United States $0.329B 0.00
Rafael Holdings (RFL) United States $0.312B 0.00
Jounce Therapeutics (JNCE) United States $0.306B 4.09
KalVista Pharmaceuticals (KALV) United States $0.301B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.272B 0.00
GlycoMimetics (GLYC) United States $0.267B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.257B 0.00
Calithera Biosciences (CALA) United States $0.243B 0.00
Xeris Pharmaceuticals (XERS) United States $0.238B 0.00
Concordia (CXRXF) Canada $0.215B 0.00
Concert Pharmaceuticals (CNCE) United States $0.210B 0.00
Ocular Therapeutix (OCUL) United States $0.195B 0.00
Nature's Sunshine Products (NATR) United States $0.186B 32.00
AcelRx Pharmaceuticals (ACRX) United States $0.184B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.178B 0.00
Taiwan Liposome (TLC) Taiwan $0.175B 0.00
Aquestive Therapeutics (AQST) United States $0.168B 0.00
IMV INC (IMV) Canada $0.149B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.145B 0.00
MEI Pharma (MEIP) United States $0.144B 0.00
Redhill Biopharma (RDHL) Israel $0.135B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.129B 0.00
CV Sciences (CVSI) United States $0.129B 0.00
CannTrust Holdings (CTST) Canada $0.119B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.099B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.092B 0.00
CTI BioPharma (CTIC) United States $0.089B 0.00
Capnia (SLNO) United States $0.085B 0.00
MediWound (MDWD) Israel $0.082B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.080B 23.91
Oasmia Pharmaceutical AB (OASMY) Sweden $0.079B 0.00
Champions Oncology (CSBR) United States $0.078B 0.00
Otonomy (OTIC) United States $0.076B 0.00
Neos Therapeutics (NEOS) United States $0.074B 0.00
PolarityTE (PTE) United States $0.073B 0.00
Aclaris Therapeutics (ACRS) United States $0.072B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.069B 0.00
Nivalis Therapeutics (ALPN) United States $0.068B 0.00
Infinity Pharmaceuticals (INFI) United States $0.066B 0.00
Pharmaxis (PXSLY) Australia $0.065B 0.00
RENEURON GP (RNUGF) United Kingdom $0.062B 0.00
Natural Alternatives (NAII) United States $0.058B 14.55
Genocea Biosciences (GNCA) United States $0.058B 0.00
Novan (NOVN) United States $0.058B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.055B 0.00
Forward Pharma (FWP) Denmark $0.055B 0.00
Medicure (MCUJF) Canada $0.055B 0.00
Mast Therapeutics (SVRA) United States $0.054B 0.00
AgeX Therapeutics (AGE) United States $0.051B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.051B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.048B 0.00
ElectroCore (ECOR) United States $0.047B 0.00
IsoRay (ISR) United States $0.044B 0.00
SCYNEXIS (SCYX) United States $0.043B 0.00
Iterum Therapeutics (ITRM) Ireland $0.040B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.040B 0.00
Mannatechorporated (MTEX) United States $0.038B 0.00
Opexa Therapeutics (ACER) United States $0.038B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.032B 0.00
Jaguar Animal Health (JAGX) United States $0.030B 0.00
Shineco (TYHT) China $0.028B 0.00
PharmAthene (ALT) United States $0.027B 0.00
India Globalization Capital (IGC) United States $0.027B 0.00
Biomerica (BMRA) United States $0.026B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.025B 0.00
ProPhase Labs (PRPH) United States $0.024B 0.00
Melinta Therapeutics (MLNT) United States $0.022B 0.00
China SXT Pharmaceuticals (SXTC) China $0.022B 0.00
Bio-Path Holdings (BPTH) United States $0.022B 0.00
Cardiome Pharma (CORV) Canada $0.020B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.016B 0.00
Heat Biologics (HTBX) United States $0.016B 0.00
VAXART, INC (VXRT) United States $0.015B 0.00
Flex Pharma (SLRX) United States $0.015B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Vical (BBI) United States $0.013B 0.00
Lipocine (LPCN) United States $0.009B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.008B 0.00
HANCOCK JAFFE (HJLI) United States $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.007B 0.00
Achieve Life Sciences (ACHV) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
RXi Pharmaceuticals (PHIO) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Can-Fite Biopharma (CANF) Israel $0.005B 0.00
Hemispherx BioPharma (AIM) United States $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00
Onconova Therapeutics (ONTX) United States $0.002B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00